A pharmacy benefit company built around
radical clarity.
Rescription was founded on a simple idea: when prescription pricing is transparent and incentives are aligned, real savings find their way to employers and members. Our patented technology and growing network of health system and PBM partners turn that idea into outcomes.
We built Rescription to fix what the existing system wouldn't.
For decades, PBMs have been operated on a misaglinged foundation
that earns more when the client pays more. Rescription was founded
to flip that broken model with 100% alignment.
Rescription is incentivized to find the most cost effective drug from the
best source for every script. The answer became RexiTM, our patented
adjudication engine, and the U.S. utility patent we were awarded in
February 2026 for bringing 3408 pricing to the point-ofsale.
Today, Rescription works alongside leading PBMs, partners with growing
networks of health systems, and serves self-funded employers and
their members across the country. The mission is the same as the day
we started: simplerpricing, aligned incentives, and savings that show
up where people actually filltheir prescriptions.
"Prescription benefits don't have to be confusing, conflicted, or unpredictable. When pricing is clear and incentives are aligned, the rest takes care of itself."
- Scott Martin, Founder & CEO
Our Promise: Radical Clarity.
It's the principle behind every product decision we make: pharmacy benefits should be transparent enough that a buyer, a broker, or a member can look at a script and understand exactly what they paid, what they saved, and why.
Pricing in real time, not after the fact.
Our patented technology applies savings at the moment a script is filled — not months later, after a rebate reconciliation nobody can fully audit.
Every claim documented. Every decision visible.
Every routing decision is logged with its reason. Clients get real-time access to the Client Dashboard, not a quarterly summary, not aggregated data.
Incentives that point the same direction.
A flat subscription model means we make the same fee whether a member fills a $10 generic or a $10,000 specialty. The math points us to the cheapest viable source, every time.
Changemakers from inside the industry - and outside of it.
The Rescription team is built from leaders with decades of experience across pharmacy, benefits, technology, and care — people who've seen the system from every side and decided to build a different one.
Scott Martin
FOUNDER & CEO
Scott Martin is an accomplished entrepreneur in the healthcare industry, currently building his fourth company, Rescription. In 2021, Scott successfully sold Remedy Analytics, Inc., a pharmaceutical analytics company he founded in Milwaukee, WI. Remedy counts many of the country’s largest brand name employers as clients comprising over two million members. Prior to that, Scott was the Founder of Martin Benefits Consulting and Martin Human Resources, one of New York City’s largest independent benefits consultants and HR outsourcing firms. Scott also played an integral role in building Oxford Health Plans from a small start-up into a dominant national player in managed care.
Steve Mirante
COO
Steve Mirante has over 35 years of experience as a large corporate plan sponsor and compensation & benefits consultant and brings an experienced “customer” perspective to Rescription’s team. He has designed large fiscally responsible programs with an “eye” on high level service delivery for members. Steve has held a number of senior corporate positions in his career most recently as the Chief Administrative Officer at CBS Corporation where his responsibilities included all compensation and benefits programs for the Company. Earlier, Steve ran large-scale consulting P&Ls at Watson Wyatt Worldwide and PricewaterhouseCoopers and started an advisory services practice group at Cigna.
Michele Goldstein
CFO
Michele Goldstein is a results-oriented executive with broad experience in strategic and financial planning having led finance at several B2B2C companies. She has participated as a senior executive for the launch of start-ups and the scaling of global companies. Prior to Rescription, Michele was SVP, Strategic Planning and Operations at AMC Networks. She was responsible for all economic aspects of the company’s distribution strategy at a time of explosive growth and emerging technologies. Prior to AMC, she led finance for Voom HD Networks, a newly launched suite of 21 HD Networks. Michele also held several senior finance positions at both WWE and Viacom/CBS.
Jon Zerden
CTO
Jon Zerden is the Chief Technology Officer at Rescription, bringing over 25 years of experience leading technology strategy and innovation across software, hardware, and product platforms. He has held senior roles at companies including EXOS, Privva, World Wrestling Entertainment, AOL, and Publishers Clearing House. Jon has partnered extensively with private equity and venture capital firms to execute value-creation strategies, with a focus on scaling high-tech, high-growth organizations across MedTech, FinTech, AdTech, and Health & Wellness. He has supported companies from pre-revenue to $200M ARR.
Richard Vaughn
CPO
Richard Vaughn is a skilled and innovative Product Strategist with 15+ years of unique experience and demonstrated success in the high-tech, healthcare, and fitness industries. He has extensive expertise in product and project management, relationship management, product development and strategy, and operational leadership. His strong record of customer-focused, data-driven decision making delivers an exceptional customer experience. Most recently Richard served as Vice President, Product Delivery at EXOS.
Andy Bisselle
CRO
Andy Bisselle is an experienced healthcare executive specializing in fund development and business strategy & growth. During his career, he served as the Director of Major Gifts at Stamford Health in Connecticut, Director of Business Development at Southwestern Vermont Healthcare in Bennington Vermont and worked on the Sales team at Allergan pharmaceuticals in the northeastern US territory. Andy accelerates business growth at Rescription by activating his extensive network of prospective investor, health system and employer partners.
Rourke Yeakley, MD
CHIEF MEDICAL ADVISOR
Dr. Yeakley is a board-certified emergency medicine physician with more than 30 years of clinical experience. Passionate about the role of technology in frontline care, he has founded and co-founded multiple healthcare ventures, including three EMS transport companies. His career spans emergency medicine practice, motorsports physician work with NASCAR and IndyCar, and innovative projects recognized with U.S. and international patents. He earned his medical degree from Tufts, master’s from Cornell, and bachelor’s from the University of Maine, completing residency and serving as chief resident at the University of Arizona.
Christina Victor
VP, CLINICAL PHARMACY
Christina Victor is a multi-state licensed clinical pharmacist with extensive experience in hospital pharmacy, academia, and pharmacy leadership. She has managed federally qualified health centers, delivered patient education, and developed drug utilization strategies across multiple therapeutic areas. Christina’s pharmacy benefit management expertise has delivered more than $200 million in savings for state, health system, and employer clients. She earned her Doctor of Pharmacy from Xavier University of Louisiana and completed PGY1 and PGY2 residencies at LSU Health Sciences Center and Texas Tech University Health Sciences Center.
Eric Tvedt
DIRECTOR, PHARMACY OPS
Eric Tvedt is a healthcare operations and Pharmaceutical Benefits Management (PBM) Leader- designing and optimizing operational teams, systems, and processes to deliver multimillion-dollar savings for his clients. Over the past 15+ years, he has leveraged expertise in benefits/health plan design, policy/process development, and new business implementations project management to ensure successful transitions of clients. Eric works hard to drive quality improvement programs and workflow streamlining initiatives, focusing on delivering best-in-class service for our clients.
Julie Martin
DIRECTOR, CUSTOMER CARE
Julie Martin is a seasoned global strategy and operations leader with over 30 years of experience. She has a proven track record of driving operational excellence and delivering superior customer experiences. Throughout her career, Julie has orchestrated strategies and built relationships with the partner community and business leaders by providing consultative services and sourcing solutions for the business segments. She has extensive experience building and managing complex, multi-channel, multifunctional contact centers. Julie's tenure at Cigna included leadership roles in Service Operations, Finance, Project Management, and Enterprise Global Strategy. She earned her MBA in Finance from Emory University and her BA in Economics from Trinity College.
John Studley
DIRECTOR, BIZ ANALYTICS
John Studley is currently the Director of Business Analytics at Rescription, where he supports product development and oversees all client reporting. He is a skilled analytics professional with experience delivering data-driven insights and collaborating cross-functionally with Finance, HR, and Operations. As the former Director of Analytics at Exos, he directly supported the company’s largest clients by developing KPIs and benchmarks and by building and designing dashboards and tracking tools. John holds a Bachelor’s degree in Business Management from Bentley University, underscoring his commitment to strategic, data-driven decision-making.
Taylor Hinson
DIRECTOR, PRODUCT
Taylor Hinson is a product leader with expertise in building and scaling digital products at both startups and established companies. His experience spans product management, business development, and UX design, enabling him to guide cross-functional teams and drive growth. Taylor has held leadership roles at Exos, Zeamo, and ClassPass, where he focused on product strategy, innovation, and go-to-market execution. From developing digital coaching solutions to shaping business models and supporting investor presentations, Taylor’s work has consistently delivered measurable impact across diverse organizations and markets.
Leaders inside & outside the industry agree.
Voices from healthcare policy, sport, and the broader public square — all calling for the kind of clarity Rescription was built to deliver.
Having dedicated years to both the basketball court and the healthcare industry, I've seen the power of transparency and simplicity in action. Rescription epitomizes these principles, offering a game-changing approach that truly empowers the people. With its commitment to providing the lowest price for every drug, absolutely no mark-ups, and a completely transparent, no-spread pricing model, Rescription is a true champion in the healthcare arena. Just as I've strived to empower my players on the court, Rescription gives the power back to the people, making prescription drug choices straightforward, fair, and affordable for all.
Mike Dunleavy Sr.
EXECUTIVE PARTNER
Former NBA Player & Head Coach
As the Chairman of a national legislative Health and Human Services Task Force for over 4 years, my goal was to enhance the well-being of all Americans by finding and offering effective and impactful healthcare solutions. Prescription drug prices are often patients’ greatest personal healthcare expense. Rescription has emerged as an exemplary solution that aligns perfectly with my vision. Rescription's innovative approach to purchasing and providing prescription drugs not only fosters price transparency and simplicity, but it also gives patients and providers critical information and drug pricing to help them make informed decisions that will positively impact their lives. I commend Rescription for their team's dedication to improving the pharmacy benefit industry for every American.
Senator Judson Hill
EXECUTIVE PARTNER
Former Chairman, National Legislative Health & Human Services Task Force • Georgia
OUR BLOG